TRAIL, Fas Ligand, TNF and TLR3 in Cancer
Springer International Publishing AG, 2018
172,25 €On orderDelivery: 2-3 weeks
Death receptors, including TRAIL-R1, TRAIL-R2, Fas and TNF-RI, owing to their ability to trigger apoptosis and to contribute to the elimination of cancer cells by the immune system have been considered, to variable extent, as important therapeutic targets for cancer therapy.
- ISBN-13
- 9783319860060
- ISBN-10
- 3319860062
- Publisher
- Springer International Publishing AG
- Year
- 2018
- Publication date
- 2018-08-12
- Pages
- 317
- Dimensions
- 235x155x